Systemic Markers of Adaptive and Innate Immunity Are Associated with COPD Severity and Spirometric Disease Progression
Preprint
Abstract
The progression of chronic obstructive pulmonary disease (COPD) is associated with marked alterations in circulating immune cell populations, but no studies have characterized alterations in these cell types across the full spectrum of lung function impairment in current and former smokers. In 6,299 subjects from the COPDGene and ECLIPSE studies, we related Coulter blood counts and proportions to cross-sectional FEV 1 adjusting for current smoking status. We also related cell count measures to three-year change in FEV 1 in ECLIPSE subjects. In a subset of subjects with blood gene expression data, we used cell type deconvolution methods to infer the proportions of immune cell subpopulations, and we related these to COPD clinical status. We observed that FEV 1 levels are positively correlated with lymphocytes and negatively correlated with myeloid populations such as neutrophils and monocytes. In multivariate models, absolute cell counts and proportions were associated with cross-sectional FEV 1 , and lymphocytes, monocytes, and eosinophil counts were predictive of three-year change in lung function. Using cell type deconvolution to study immune cell subpopulations, we observed that subjects with COPD had a lower proportion of CD4+ resting memory cells and naive B cells compared to non-COPD smokers. Alterations in circulating immune cells in COPD support a mixed pattern of lymphocyte suppression and an enhanced myeloid cell immune response. Cell counts and proportions contribute independent information to models predicting lung function suggesting a critical role for immune response in long-term COPD outcomes. Cell type deconvolution is a promising method for immunophenotyping in large cohorts.Keywords
All Related Versions
- Published version: American Journal of Respiratory Cell and Molecular Biology, 58 (4), 500.
This publication has 34 references indexed in Scilit:
- Inflammatory triggers associated with exacerbations of COPD orchestrate plasticity of group 2 innate lymphoid cells in the lungsNature Immunology, 2016
- Local and systemic neutrophilic inflammation in patients with lung cancer and chronic obstructive pulmonary diseaseBMC Immunology, 2013
- Behavioral and Structural Differences in Migrating Peripheral Neutrophils from Patients with Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Effects of tobacco smoke on immunity, inflammation and autoimmunityJournal of Autoimmunity, 2010
- Systemic manifestations and comorbidities of COPDEuropean Respiratory Journal, 2009
- Peripheral T Cell Functions Correlate with the Severity of Chronic Obstructive Pulmonary DiseaseThe Journal of Immunology, 2009
- Increased intracellular T helper 1 proinflammatory cytokine production in peripheral blood, bronchoalveolar lavage and intraepithelial T cells of COPD subjectsClinical and Experimental Immunology, 2007
- Airway and Systemic Inflammation and Decline in Lung Function in Patients With COPDChest, 2005
- Systemic inflammation in COPD visualised by gene profiling in peripheral blood neutrophilsThorax, 2005
- Peripheral blood lymphocyte cell subsets in subjects with chronic obstructive pulmonary disease: association with smoking, IgE and lung functionRespiratory Medicine, 1997